Novartis AG and Ionis Pharmaceuticals Renew Collaboration on Lp(a)-Driven CVD Drug
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) has returned to US-based Ionis Pharmaceuticals Inc., (NASDAQ:...
Deals
Chia Tai Tianqing Secures Exclusive Rights to InventisBio’s D-1553 in China Licensing Deal
China-based Chia Tai Tianqing has signed a licensing agreement with compatriot firm InventisBio, securing exclusive...
Kunshan Yiyuan Medical Technology Secures Over RMB 100 Million in Series B Financing
Kunshan Yiyuan Medical Technology Co., Ltd (Medical Source), a company in China that specializes in...
HuidaGene Strikes Licensing Deal with Kactus Biosystems for Gene Editing Enzyme hfCas12Max
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced a licensing agreement with fellow Shanghai-based firm...
Lee’s Pharmaceutical Subsidiary Zhaoke Ophthalmology Partners with Eyebright Medical Technology
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) subsidiary, Zhaoke Ophthalmology Ltd (HKG: 6622), has entered...
BeiGene and Bristol-Myers Squibb/Celgene Settle Partnership, Termination Set for 2023
BeiGene (NASDAQ: BGNE) has announced a settlement and termination agreement with US firm Bristol-Myers Squibb/Celgene...
Huaboron Neutron Technology Secures Over RMB 100 Million in Angel Financing for BNCT System
Huaboron Neutron Technology (Hangzhou) Co., Ltd (HBNCT) has reportedly secured more than RMB 100 million...
ICE Bioscience Secures Series B+ Financing to Boost Integration Capabilities
Beijing-based Contract Research Organization (CRO) ICE Bioscience has reportedly raised close to RMB 100 million...
Biogen Inc. to Acquire Reata Pharmaceuticals in $7.3 Billion Deal
US-based Biogen Inc., (NASDAQ: BIIB) has announced that it has reached an agreement to fully...
EQRx Inc. to be Acquired by Revolution Medicines in All-Stock Transaction
US-based EQRx Inc. (NASDAQ: EQRX) has revealed that a definitive agreement has been signed for...
GSK Partners with Zuellig Pharma for Vaccine Distribution and Cold-Chain Management in Asia-Pacific
GlaxoSmithKline (GSK; NYSE: GSK), a leading global vaccine manufacturer, has signed an agreement with Philippines-based...
Mabwell Bioscience Secures Licensing Deals for Denosumab Biosimilars in Egypt and Pakistan
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced separate licensing and commercialization agreements...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Guangzhou Wondfo Biotech Partners with Indonesia’s Kimia Farma in IVD Field
China-based Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482) has entered into a partnership with Indonesia’s...
InxMed Partners with GeneQuantum Healthcare to Develop Innovative ADCs
China-based firm InxMed (Nanjing) Co., Ltd has announced a strategic partnership with compatriot firm GeneQuantum...
Sansure Biotech Partners with Indonesian Firm for Localized Molecular Diagnostic Production
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
NK Celltech and RongCan Biotech Partner to Advance mRNA NK Cell Therapy and LNP Delivery System
Shanghai-based NK Celltech and RongCan Biotech have entered into a partnership agreement to establish a...
CASI Pharmaceuticals Enters Assignment Agreement with Mundipharma for Folotyn Commercialization in China
US-based CASI Pharmaceuticals Inc., (NASDAQ: CASI) has announced the execution of an assignment agreement with...
Shanghai Junshi Biosciences Partners with Zein Biotechnology for PCSK9 mAb Commercialization in China
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced a partnership with...
Mindray Bio-Medical Electronics to Acquire Majority Stake in DiaSys Diagnostic Systems
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical device company based in...